Follow
Bart Verlinden
Bart Verlinden
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
In vivo pharmacokinetics, biodistribution and toxicity of antibody-conjugated gold nanoparticles in healthy mice
N Daems, B Verlinden, K Van Hoecke, T Cardinaels, S Baatout, ...
Journal of biomedical nanotechnology 16 (6), 985-996, 2020
142020
Gamma radiolytic stability of the novel modified diglycolamide 2, 2′-oxybis (N, N-didecylpropanamide)(mTDDGA) for grouped actinide extraction
B Verlinden, K Van Hecke, A Wilden, M Hupert, B Santiago-Schübel, ...
RSC advances 12 (20), 12416-12426, 2022
112022
Dosimetry and methodology of gamma irradiation for degradation studies on solvent extraction systems
B Verlinden, P Zsabka, K Van Hecke, K Verguts, LC Mihailescu, G Modolo, ...
Radiochimica Acta 109 (1), 61-72, 2021
92021
Solvent Optimization Studies for a New EURO-GANEX Process with 2,2’-Oxybis(N,N-di-n-decylpropanamide) (mTDDGA) and Its Radiolysis Products
B Verlinden, A Wilden, K Van Hecke, R JM Egberink, J Huskens, ...
Solvent Extraction and Ion Exchange 41 (1), 59-87, 2023
62023
Quantification of boron in cells for evaluation of drug agents used in boron neutron capture therapy
B Verlinden, K Van Hoecke, A Aerts, N Daems, A Dobney, K Janssens, ...
Journal of Analytical Atomic Spectrometry 36 (3), 598-606, 2021
62021
Application of Methylated Diglycolamides in the EURO-GANEX Process
A Wilden, P Kowalski, W Verboom, A Geist, G Modolo, B Verlinden
43rd Actinide Separations Conference 2019, 2019
12019
Effect of ionizing radiation on solvent extraction systems for the separation of minor actinides
B Verlinden
2022
Optimization of Boron Determination with ICP-MS for Boron Neutron Capture Therapy (BNCT) Studies in Vitro
B Verlinden
Universiteit Antwerpen, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–8